Structure elucidation of platelet activating factor derived from human neutrophils.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1984-06-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-291X(84)90751-4PMID 6430285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative analysis of platelet activating factor (AGEPC) by fast atom bombardment mass spectrometry

  1984cited by this paper
• Application of selected ion monitoring to determination of platelet-activating factor.

  1983cited by this paper
• Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation

  1982cited by this paper
• Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation.

  1982cited by this paper
• Platelet-activating factor (PAF-acether) and macrophages. II. Phagocytosis-associated release of PAF-acether from rat peritoneal macrophages.

  1981cited by this paper
• Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

  1981cited by this paper
• Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.

  1980cited by this paper
• Platelet‐Activating Factor (PAF‐Acether) Secretion from Platelets: Effect of Aggregating Agents

  1980cited by this paper
• Release of platelet‐activating factor (PAF‐acether) from alveolar macrophages by the calcium ionophore A 23187 and phagocytosis

  1980cited by this paper
• Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils.

  1980cited by this paper
• Human neutrophil-derived platelet activating factor.

  1980cited by this paper
• Synthesis and back exchange of 18O labeled amino acids for use as internal standards with mass spectrometry.

  1979cited by this paper
• The release of a platelet-activating factor by stimulated rabbit neutrophils.

  1979cited by this paper
• [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].

  1979cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS

  1972cited by this paper
• RELEASE OF VASOACTIVE AMINES FROM RABBIT PLATELETS INDUCED BY SENSITIZED MONONUCLEAR LEUKOCYTES AND ANTIGEN

  1970cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Lipid Mass Spectrometry: A Path Traveled for 50 Years.

  2020cites this paper
• Dissecting the Mechanism of Intracellular Mycobacterium smegmatis Growth Inhibition by Platelet Activating Factor C-16

  2020cites this paper
• Oxidative Phospholipidomics in health and disease: Achievements, challenges and hopes.

  2017cites this paper
• Pathology Reviews · 1989

  2011cites this paper
• Cuticular lipids of insects as potential biofungicides: methods of lipid composition analysis

  2011cites this paper
• The influence of platelet activating factor on the effects of platelet agonists and antiplatelet agents in vitro

  2009cites this paper
• Identification of Disease Markers in Human Cerebrospinal Fluid Using Lipidomic and Proteomic Methods

  2005cites this paper
• Platelet activating factor (PAF) and lyso-PAF in psoriasis

  2004cites this paper
• Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium

  2003cites this paper
• Novel molecular analogues of phosphatidylchoilines in a lipid extract from bovine brain : I-long-chaiin acyl-2s h

  2002cites this paper
• PAF, a putative mediator of oral inflammation.

  2000cites this paper
• Platelet-Activating Factor: Biosynthesis, Biodegradation, Actions

  1997cites this paper
• Qualitative and quantitative assessment of platelet activating factors

  1997cites this paper
• PAF and Antigen-Induced Bronchial Hyperreactivity in Guinea Pigs

  1996cites this paper
• Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes.

  1996cites this paper
• Structural and (Patho)physiological diversity of PAF

  1995cites this paper
• The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis.

  1995cites this paper
• Salivary PAF Levels Correlate with the Severity of Periodontal Inflammation

  1995cites this paper
• A family of phospholipid autacoids: occurrence, metabolism and bioactions.

  1995cites this paper
• Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.

  1994cites this paper
• The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.

  1994cites this paper
• 8 – Biological Properties of Platelet-Activating Factor

  1994cites this paper
• Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.

  1994cites this paper
• Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.

  1994cites this paper
• 7 – Cellular Sources of Platelet-Activating Factor and Related Lipids

  1994cites this paper
• Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.

  1993cites this paper
• Preclinical studies with platelet-activating factor antagonists in models of septic shock.

  1993cites this paper
• PAF molecular heterogeneity: pathobiological implications.

  1993cites this paper
• Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.

  1993cites this paper
• Radiation-induced increased platelet-activating factor activity in mixed saliva.

  1993cites this paper
• Release of newly synthesized platelet-activating factor (PAF) from human polymorphonuclear leukocytes under in vivo conditions. Contribution of PAF-releasing factor in serum.

  1992cites this paper
• Nedocromil sodium inhibits the increase in airway reactivity induced by platelet activating factor in humans.

  1992cites this paper
• Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colony-stimulating factor-primed human eosinophils.

  1992cites this paper
• Platelet-Activating Factor and Related Compounds

  1992cites this paper
• Pregnancy-associated remodeling of rabbit endometrial platelet-activating factor receptors.

  1992cites this paper
• Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.

  1992cites this paper
• Analysis of platelet-activating factor by gas chromatography-mass spectrometry: low-energy electron impact of the corresponding 3-acetyl-2-tert.-butyldimethylsilyl derivative.

  1991cites this paper
• Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.

  1991cites this paper
• Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.

  1991cites this paper
• Molecular heterogeneity of platelet-activating factor (PAF) in rat glandular stomach determined by gas chromatography/mass spectrometry. PAF molecular species changes upon water-immersion stress

  1991cites this paper
• Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle.

  1991cites this paper
• Assays for measuring arachidonic acid release from phospholipids.

  1991cites this paper
• Electrospray ionization for analysis of platelet-activating factor.

  1991cites this paper
• Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells.

  1991cites this paper
• Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.

  1991cites this paper
• Isotopic exchange during derivatization of platelet activating factor for gas chromatography-mass spectrometry.

  1991cites this paper
• Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension.

  1991cites this paper
• Quantitative analysis of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.

  1990cites this paper
• The presence of platelet-activating factor associated with eosinophil and/or neutrophil accumulations in the pleural fluids.

  1990cites this paper
• Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.

  1990cites this paper
• [Platelet activating factor--a biologically active phospholipid].

  1990cites this paper
• The use of HPLC for the determination of lipids in biological materials

  1990cites this paper
• Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.

  1990cites this paper
• Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.

  1990cites this paper
• Analysis of platelet-activating factor by GC-MS after direct derivatization with pentafluorobenzoyl chloride and heptafluorobutyric anhydride.

  1990cites this paper
• Antagonists of platelet-activating factor: chemistry, pharmacology and clinical applications.

  1990cites this paper
• Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry.

  1989cites this paper
• The synthesis, catabolism, and pathophysiological role of platelet-activating factor.

  1989cites this paper
• Biosynthesis of paf-acether. X. Phorbol myristate acetate-induced paf-acether biosynthesis and acetyltransferase activation in human neutrophils.

  1989cites this paper
• [Clinical significance of studies of platelet activating factor (review of the literature)].

  1989cites this paper
• Potential phospholipid source(s) of arachidonate used for the synthesis of leukotrienes by the human neutrophil.

  1989cites this paper
• A PAF antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep.

  1989cites this paper
• Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism.

  1989cites this paper
• Acute and long‐term pulmonary effects of platelet‐activating factor

  1989cites this paper
• Biochemistry of Platelet-Activating Factor: A Unique Class of Biologically Active Phospholipids 1

  1989cites this paper
• Development of a mass spectrometric method to quantitate platelet activating factor in mouse urine.

  1989cites this paper
• Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.

  1989cites this paper
• Novel molecular analogues of phosphatidylcholines in a lipid extract from bovine brain: 1-long-chain acyl-2-short-chain acyl-sn-glycero-3-phosphocholines.

  1989cites this paper
• Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry.

  1989cites this paper
• Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man.

  1988cites this paper
• Radioligand competitive binding methodology for the evaluation of platelet-activating factor (PAF) and PAF-receptor antagonism using intact canine platelets.

  1988cites this paper
• 1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil.

  1988cites this paper
• Natural antagonists of platelet‐activating factor

  1988cites this paper
• The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion.

  1988cites this paper
• Platelet-activating factor as a mediator of allergic disease.

  1988cites this paper
• Phagocytosis of bacteria and phospholipid degradation.

  1988cites this paper
• PAF antagonists. Their potential therapeutic role in asthma.

  1988cites this paper
• Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. Involvement of the cholinephosphotransferase pathway in response to the phorbol esters.

  1988cites this paper
• Structure and function of proton translocating ATPase in plasma membranes of plants and fungi.

  1988cites this paper
• PAF Antagonists

  1988cites this paper
• Early biochemical events in leukocyte activation.

  1988cites this paper
• Application of thermospray high-performance liquid chromatography/mass spectrometry for the determination of phospholipids and related compounds.

  1987cites this paper
• Analysis of phospholipid molecular species in rat lung as dinitrobenzoate diglycerides by electron capture negative chemical ionization mass spectrometry.

  1987cites this paper
• Metabolism of platelet-activating factor in isolated perfused rat lung.

  1987cites this paper
• Chemical Synthesis and Mass Spectrometry of PAF

  1987cites this paper
• Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.

  1987cites this paper
• Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain.

  1987cites this paper
• Measurement of platelet-activating factor by physicochemical technique s.

  1987cites this paper
• A plant lipid and the platelet-activating factor stimulate ATP-dependent H+ transport in isolated plant membrane vesicles

  1987cites this paper
• Platelet activating factor; chemical and biochemical characteristics.

  1987cites this paper
• Species-specific variations in the molecular heterogeneity of the platelet-activating factor.

  1987cites this paper
• Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection.

  1987cites this paper
• Simple and complex lipids: their occurrence, chemistry, and biochemistry.

  1987cites this paper
• Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.

  1987cites this paper
• Composition of Alkyl Ether-Linked Phospholipids in Mammalian Tissues

  1987cites this paper
• Chapter 6 HPLC of the Arachidonoyl Molecular Species of Glycerophospho-Lipids in Alveolar Macrophages and Immune Responses

  1987cites this paper
• Chapter 12 GC/MS of Molecular Species of Glycerophospholipids

  1987cites this paper
• The final step in the de novo biosynthesis of platelet-activating factor. Properties of a unique CDP-choline:1-alkyl-2-acetyl-sn-glycerol choline-phosphotransferase in microsomes from the renal inner medulla of rats.

  1987cites this paper
• Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells.

  1987cites this paper
• Interrelationships in the Metabolism of Platelet-Activating Factor and Arachidonate in Neutrophils

  1987cites this paper